Search Results For ''

  • Wildcat delivers Australia’s largest undeveloped lithium resource

    Mineral exploration business Wildcat Resources (ASX: WC8) has unveiled a significant resource estimate for its Tabba Tabba project in the Pilbara region of Western Australia, consisting of 74.1 million tonnes at a grade of 1.0 per cent lithium. According to the company, the project now holds Australia’s largest undeveloped publicly reported hard-rock lithium deposit. The

    Read More
    Public
  • AML3D raise to fund doubling of US capacity and other growth initiatives

    AML3D (ASX:AL3) announced the successful completion of a two-tranche institutional placement (“Placement”) to sophisticated investors, raising approximately $30 million. The Placement will see around 157.9 million new fully paid ordinary shares in AML3D issued at a price of $0.19 per share. The Placement was strongly supported by both existing AML3D shareholders and new institutional investors

    Read More
    Public
  • Encounter Resources drill results confirm ‘high-grade’ niobium discovery

    Encounter Resources (ASX:ENR) rose after announcing that the first reverse circulation (RC) drilling results from its Green prospect at the Aileron project in the West Arunta region of WA hosts extensive, enriched, high-grade niobium mineralisation in the upper portion of the system. Of the four initial RC holes completed in Green’s western area, three returned

    Read More
    Public
  • Singular Health Group signs MOU and completes equity placement

    Medical technology company Singular Health Group rose after it announced the signing of a Memorandum of Understanding (MOU) with Provider Network Solutions (PNS) to collaborate on a technical proof-of-concept and commercial pilot within the PNS Network. Singular Health also announced the completion of a successful equity placement of AUD3.7M at $0.09 per share, including an

    Read More
    Public
  • Resonance soars on $14m contract win with big pharma

    The share price of healthcare technology and services business Resonance Health (ASX: RHT) surged by more than 50 per cent on Tuesday after the company nailed down a two-year clinical trial agreement with Indian multinational pharmaceutical titan, Sun Pharmaceuticals. The $13.775 million deal will see Resonance act as the local Australian sponsor and provide clinical

    Read More
    Public
  • Petratherm surges on ‘outstanding’ Rosewood metallurgical results

    Petratherm (ASX:PTR) rallied strongly after announcing results from an initial trial heavy mineral sand (HMS) separation test using samples collected from historic drill holes stored at the South Australian Core Library (CAR series drill holes). The composite samples were collected from widely spaced contiguous drill holes along a 2.5-kilometre-long traverse on the eastern side of

    Read More
    Public